Abiomed fiscal 4th quarter revenue increases 24 percent to $28.
Non-Impella revenue was $6.1 million for the fourth quarter of fiscal 2011, 2 percent lower than $6.2 million in the fourth quarter of fiscal 2010. Non-GAAP net gain, which is referred to later in this press release for the 4th quarter of fiscal 2011, was $0.6 million, or $0.01 per diluted share versus a non-GAAP net loss of $4.1 million or $0.11 per simple and diluted share, in the fourth one fourth of fiscal 2010. The full 2011 fiscal season non-GAAP net loss was $2.1 million or $0.06 per share compared to a non-GAAP net loss of $13.5 million or $0.37 per share for fiscal 2010. GAAP net loss for the fourth one fourth of fiscal 2011 was $1.8 million, or $0.05 per basic and diluted share, compared to GAAP net gain of $1.0 million, or $0.03 per diluted and basic share for the fourth quarter of fiscal 2010.Asthma and allergic rhinitis frequently coexist, and treatment of allergic rhinitis can improve asthma control. Not all snuffly noses are due to allergy. Several conditions might mimic the symptoms of allergic rhinitis and should be considered in the differential diagnosis. Snuffly noses in infants are more due to infection than allergy typically, are only occasionally because of allergy and so are unrelated to dietary elements, even if coexistent meals allergy is present. Allergy testing can help recognize triggers to facilitate allergen avoidance and help style specific immunotherapy.